Fulminant and late onset hepatic failure

British Journal of Anaesthesia

Volumn 77, Issue 1, 1996, Pages 90-98

  Gimson, A E S ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Complications, cerebral oedema; Complications, jaundice; Complications, liver disease; Liver, function

Indexed keywords

PARACETAMOL;

ACUTE HEPATITIS; BRAIN EDEMA; DRUG OVERDOSE; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER FAILURE; LIVER TOXICITY; LIVER TRANSPLANTATION; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

EID: 0029900059     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/77.1.90     Document Type: Article

References (104)

1. Akriviadis EA, Redeker AG. Fulminant hepatitis A in intravenous drug users with chronic liver disease, Annals of Internal Medicine 1989; 110: 838-839.
2. Almdal T, Schroeder T, Ranek L. Cerebral blood flow and liver function in patients with encephalopathy due to acute and chronic liver diseases. Scandinavian Journal of Gastroenterology 1989; 24: 299-303.
3. Asher LVS, Innis BL, Shrestha MP, Ticehurst J, Baze WB. Virus-like particles in the liver of a patient with fulminant hepatitis and antibody to hepatitis E virus. Journal of Medical Virology 1990; 31: 229-233.
4. Baudouin SV, Howdle P, O'Grady JG, Webster NR. Acute lung injury in fulminant hepatic failure following paracetamol poisoning. Thorax 1995; 50: 399-402.
5. Basile AS, Pannell L, Jaouni T, Gammal SH, Fales HM, Jones EA, Skolnick P. Brain concentrations of benzo-diazepines are elevated in an animal model of hepatic encephalopathy. Proceedings of National Academy of Science USA 1990; 87: 5263-5267.
6. Basile AS, Hughes RD, Harrison PM, Jones EA, Williams R, Skolnick P. Elevated brain concentrations of 1,4-benzo-diazepines in fulminant hepatic failure. New England Journal of Medicine 1991; 325: 473-478.
7. Benhamou JP. Fulminant and subfulminant hepatic failure: definition and causes. In: Williams R, Hughes RD, eds. Acute Liver Failure Improved Understanding and Better Therapy. London: Mitre Press, 1991; 6-10.
8. Berman DH, Leventhal RI, Gavaler JS, Cadoff EM, Van Thiel DH. Clinical differentiation of fulminant Wilsonian hepatitis from other causes of hepatic failure. Gastroenterology 1991; 100: 1129-1134.
9. Bernuau J, Rueff B, Benhamou J-P. Fulminant and subfulminant liver failure: definitions and causes. Seminars in Liver Disease 1986; 6: 97-106.
10. Bernuau J, Goudeau A, Poynard T, Dubois F, Lesage G, Yvonnet B, Degott C, Bezeaud A, Rueff B, Benhamou JP. Multivariate analysis of prognostic factors in fulminant hepatitis B. Hepatology 1986; 6: 648-651.
11. Bernuau J, Babany G, Bezeaud A, Benhamou JP. Does prostaglandin E1 (PGE1) prevent further aggravation in severe, or early fulminant, hepatitis? A preliminary open trial (abstract). Journal of Hepatology 1989; 9: S114.
12. Bernuau J, Benhamou JP. Classifying acute liver failure. Lancet 1993; 342: 252.
13. Bihari D, Gimson AES. Waterson M, Williams R. Tissue hypoxia in fulminant hepatic failure. Critical Care Medicine 1985; 3: 1034-1039.
14. Bihari DJ, Gimson AES, Williams R. Cardiovascular, pulmonary and renal complications of fulminant hepatic failure. Seminars in Liver Disease 1986; 6: 119-128.
15. Bihari D, Wendon J. Tissue hypoxia in fulminant hepatic failure. In: Williams R, Hughes RD, eds. Acute Liver Failure : Improved Understanding and Better Therapy. London: Mitre Press, 1991: 4244.
16. Bird GLA, Smith H, Portmann B, Alexander GJM, Williams R. Acute liver decompensation on withdrawal of cytotoxic chemotherapy and immunosuppressive therapy in hepatitis B carriers. Quarterly Journal of Medicine 1989; 73: 895-902.
17. Blei AT. Cerebral edema and intracranial hypertension in acute liver failure: distinct aspects of the same problem. Hepatology 1991; 13: 376-379.
18. Blei AT, Olafsson S, Webster S, Levy R. Complications of intracranial pressure monitoring in fulminant hepatic failure. Lancet 1993; 341: 157-158.
19. Boudjema K, Cherqui D, Jaeck D, Chenard-Neu M-P. Auxiliary liver transplantation for fulminant and sub-fulminant hepatic failure. Transplantation 1995; 59: 218-223.
20. Boyer JL, Klatskin G. Pattern of necrosis in acute viral hepatitis. Prognostic value of bridging (subacute hepatic necrosis). New England Journal of Medicine 1970; 12: 1063-1071.
21. Canalese J, Gimson AES, Davis C, Mellon PJ, Davis M, Williams R. Controlled trial of dexamethasone and mannitol for the cerebral oedema of fulminant hepatic failure. Gut 1982; 23: 625-629.
22. Canalese J, Gove C, Gimson AES, Wilkinson SP, Wadle EN, Williams R. Reticuloendothelial system and hepatocyte function in fulminant hepatic failure. Gut 1982; 23: 265-269.
23. Carson JL, Strom BL, Duff A, Gupta A, Shaw M, Lundin FE, Das K. Acute liver disease associated with erythromycins, sulphonamides and tetracyclines. Annals of Internal Medicine 1993; 119: 576-583.
24. Connor RW, Lorts G, Gilbert DN. Lethal herpes simplex virus type 1 hepatitis in a normal adult. Gastroenterology 1979; 76: 590-594.
25. Davenport A, Will EJ, Davison AM. Effect of posture on intracranial pressure and cerebral perfusion in patients with fulminant hepatic and renal failure after acetaminophen self-poisoning. Critical Care Medicine 1980; 18: 286-289.
26. Davies MH, Morgan-Capner P, Portmann B, Wilkinson SP, Williams R. A fatal case of Epstein-Barr virus infection with jaundice and renal failure. Postgraduate Medical Journal 1980; 56: 794-795.
27. Davies MH, Wilkinson SP, Hanid MA, Portmann B, Brudenell JM, Newton JR, Williams R. Acute liver disease with encephalopathy and renal failure in late pregnancy and the early puerperium. A study of fourteen patients. British Journal of Obstetrics and Gynaecology 1980; 87: 1005-1014.
28. Dawson DJ, Babbs C, Warnes TW, Neary RH. Hypophosphatemia in acute liver failure. British Medical Journal 1987; 295: 1312-1313.
29. Donovan JP, Shaw BW jr, Langnas AN, Sorrell MF. Brain water and acute liver failure: the emerging role of intracranial pressure monitoring. Hepatology 1992; 16: 267-268.
30. Ede RJ, Gimson AES, Bihari D, Williams R. Controlled hyperventilation in the prevention of cerebral oedema in fulminant hepatic failure. Journal of Hepatology 1986; 2: 43-51.
31. Ede RJ, Williams R. Reyes syndrome in adults. British Medical Journal 1988; 296: 517.
32. Emond JC, Aran PP, Whitington PF, Broelsch CE, Baker AL. Liver transplantation in the management of fulminant hepatic failure. Gastroenterology 1989; 96: 1583-1588.
33. European Association for the Study of the Liver. Randomised trial of steroid therapy in acute liver failure. Gut 1979; 20: 620-623.
34. Feray C, Gigou M, Samuel D, Reyes G, Bernuau J, Reynes M, Bismuth H, Brechot C. Hepatitis C virus RNA and hepatitis B virus DNA in serum and liver of patients with fulminant hepatitis. Gastroenterology 1993; 104: 549-555.
35. Forbes A, Alexander GJ, O'Grady JG, Keays R, Gullan R, Dawling S, Williams R. Thiopental infusion in the treatment of intracranial hypertension complicating fulminant hepatic failure. Hepatology 1989; 10: 306-310.
36. Forbes A, Williams R. Increasing age - an important adverse prognostic factor in hepatitis A virus infection. Journal of the Royal College of Physicians of London 1988; 22: 237-239.
37. Gallinger S, Greig PD, Levy G, Blendis LM, Roberts EA, Superina RA, Taylor BR, Strasberg SM, Phillips MJ, Langer B. Liver transplantation for acute and subacute fulminant hepatic failure. Transplantation Proceedings 1989; 21: 2435-2438.
38. Gerber MA, Thung SN, Shen S, Stromeyer FW, Ishak KG. Phenotypic characterization of hepatic proliferation. Antigenic expression of proliferating epithelial cells in fetal liver, massive hepatic necrosis and nodular transformation of the liver. American Journal of Pathology 1983; 110: 70-74.
39. Gimson AES, Braude S, Mellon P, Canalese J, Williams R. Earlier charcoal haemoperfusion in fulminant hepatic failure. Lancet 1982; ii: 681-683.
40. Gimson AES, Tedder RS, White YS, Eddleston ALWF, Williams R. Serological markers in fulminant hepatitis B. Gut 1983; 24: 615-617.
41. Gimson AES, O'Grady J, Ede R, Portmann B, Williams R. late-onset hepatic failure: clinical, serological and histological features. Hepatology 1986; 6: 228-294.
42. Gohda E, Tsubouchi H, Nakayama H, Hirono S, Arakaki N, Yamamoto I, Hashimoto S, Daikuhara Y. Human hepatocyte growth factor in blood of patients with fulminant hepatic failure: basic aspects. Digestive Diseases and Sciences 1991; 36: 785-790.
43. Gordon FD, Anastopoulos H, Khettry U, Loda M, Jenkins RL, Lewis WD, Trey C. Hepatitis C infection: a rare cause of fulminant hepatic failure. American Journal of Gastro-enterology 1995; 90: 117-120.
44. Govindarajan S, Chin KP, Redeker AG, Peters RL. Fulminant B viral hepatitis: role of delta agent. Gastroenterology 1984; 86: 1417-1420.
45. Grimm G, Ferenci P, Katzenschlager R, Madl C, Schnee-weiss B, Laggner AN, Lenz K, Gangl A. Improvement of hepatic encephalopathy treated with flumanzenil. Lancet 1991; 2: 1392-1394.
46. Hanau C, Munoz SJ, Rubin R. Histopathological heterogeneity in fulminant hepatic failure. Hepatology 1995; 21: 345-351.
47. Harrison PM, Keays R, Bray GP, Alexander GJM, Williams R. Late N-acetylcysteine administration improves outcome for patients developing paracetamol-induced fulminant hepatic failure. Lancet 1990; i: 1572-1573.
48. Harrison PM, Wendon JA, Gimson AES, Alexander GJM, Williams R. Improvement by N-acetylcysteine of haemodynamics and oxygen transport in fulminant hepatic failure. New England Journal of Medicine 1991; 324: 1852-1857.
49. Henson DE, Crimley PM, Strano AJ. Postnatal cyto-megalovirus hepatitis: an autopsy and liver biopsy study. Human Pathology 1974; 5: 93-103.
50. Horney JT, Galambos JT. The liver during and after fulminant hepatitis. Gastroenterology 1977; 73: 639-645.
51. Hughes R, Williams R. Clinical experience with charcoal and resin hemoperfusion. Seminars in Liver Disease 1986; 6: 164-173.
52. Ishak KG. Viral hepatitis: the morphologic spectrum. In: Gall EA, Mostofi FK, eds. The Liver. International Academy of Pathology Monographs No 13. Baltimore: Williams and Wilkins, 1973: 218-268.
53. Iwatsuki S, Stieber AC, Marsh JW, Tzakis AG, Todo S, Koneru B, Makowka L, Gordon RD, Starzl TE. Liver transplantation for fulminant hepatic failure. Transplantation Proceedings 1989; 21: 2431-2434.
54. Joo F. A unifying concept on the pathogenesis of brain oedemas. Neuropathology and Applied Neurobiology 1990; 13: 161-176.
55. Kato M, Hughes RD, Keays RT, Williams R. Electron microscopic study of brain capillaries in cerebral edema from fulminant hepatic failure. Hepatology 1992; 15: 1060-1066.
56. Keays R, Harrison PM, Wendon JA, Forbes A, Gove C, Alexander GJ, Williams R. Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial. British Medical Journal 1991; 303: 1026-1029.
57. Kumar S, Rex DK. Failure of physicians to recognize acetaminophen hepatotoxicity in chronic alcoholics. Archives of Internal Medicine 1991; 151: 1189-1191.
58. Langley PG, Forbes A, Hughes RD, Williams R. Thrombinantithrombin III complex in fulminant hepatic failure: evidence for disseminated intravascular coagulation and relationship to outcome. European Journal of Clinical Investigation 1990; 20: 27-631.
59. Larsen FS, Knudsen GM, Paulson OB, Vilstrup H. Cerebral blood flow autoregulation is absent in rats with thioacetamide-induced hepatic failure. Journal of Hepatology 1994; 21: 491-495.
60. Liang TJ, Jeffers L, Reddy RK, Hasegawa K, Rimon N, Wands JR, Ben-Porath E. Fulminant or subfulminant non-A, non-B viral hepatitis: the role of hepatitis C and E viruses. Gastroenterology 1993; 104: 556-562.
61. Licht H, Seeff LB, Zimmerman HJ. Apparent potentiation of acetaminophen hepatotoxicity by alcohol. Annals of Internal Medicine 1980; 92: 511.
62. Lidofsky SD, Bass NM, Prager MC, Washington DE, Read AE, Wright TL, Ascher NL, Roberts JP, Scharschmidt BF, Lake JR. Intracranial pressure monitoring and liver transplantation for fulminant hepatic failure. Hepatology 1992; 16: 1-7.
63. McKenzie R, Fried MW, Sallie R, Conjeevaram H, Di Bisceglie AM, Park Y, Savarese B, Kleiner D, Tsokos M, Luciano C. Hepatic failure and lactic acidosis due to Fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B. New England Journal of Medicine 1995; 333: 1099-1105.
64. Metselaar HJ, Hesselink EJ, de Rave S, ten Kate FJ, Lameris JS, Groenland TH, Reuvers CB, Weimar W, Terpstra OT, Schalm SW. Recovery of failing liver after auxiliary heterotopic liver transplantation. Lancet 1990; 335: 1156-1157.
65. Mitchell I, Wendon J, Fitt S, Williams R. Anti-tuberculous therapy and acute liver failure. Lancet 1995; 345: 555-556.
66. Morishita K, Kodo H, Asano S, Fujii H, Miwa S. Fulminant varicella hepatitis following bone marrow transplantation. Journal of the American Medical Association 1985; 253: 511.
67. Mullen KD, Martin JV, Mendelson WB, Bassett ML, Jones EA. Could an endogenous benzodiazepine ligand contribute to hepatic encephalopathy? Lancet 1988; i: 457-459.
68. Munoz SJ, Robinson M, Northrup B, Bell R, Moritz M, Jarrell B, Martin P, Maddrey WC. Elevated intracranial pressure and tomography of the brain in fulminant hepatic failure. Hepatology 1991; 13s: 209-212.
69. O'Grady JG, Alexander GJM, Thick M, Potter D, Calne RY, Williams R. Outcome of liver transplantation in the aetiological and clinical variants of acute liver failure. Quarterly Journal of Medicine 1988; 69: 817-824.
70. O'Grady J, Gimson AES, O'Brien C, Pucknell A, Hughes RD, Williams R. Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure. Gastroenterology 1988; 94: 1186-1192.
71. O'Grady JG, Alexander GJM, Hallyar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989; 97: 439-445.
72. O'Grady JG, Schalm SW, Williams R. Acute liver failure; redefining the syndrome. Lancet 1993; 342: 273-275.
73. Osano Y, Yoshikawa T, Suga S, Yazaki T, Kondo K, Yamanishi K. Fatal fulminant hepatitis in an infant with human herpes virus-6 infection. Lancet 1991; 335: 862-863.
74. Papaevangelou G, Tassopoulos N, Roumeliotou-Karayannis A, Richardson C. Aetiology of fulminant viral hepatitis in Greece. Hepatology 1984; 4: 369-372.
75. Pappas S, Ferenci P, Jones EA. Evidence against the hypothesis that cerebral oedema in FHF is due to decreased neural Na-K ATPase activity. Hepatology 1983; 3: 848 (Abstract).
76. Pereira LMMB, Langley PG, Hayllar KM, Tredger JM, Williams R. Coagulation factor V and VIII/V ratio as predictors of outcome in paracetamol induced fulminant hepatic failure: relation to other prognostic indicators. Gut 1992; 33: 98-102.
77. Pernambuco R, Langley PG, Hughes R, Izumi S, Williams R. Activation of the fibrinolytic system in patients with fulminant liver failure. Hepatology 1993; 18: 1350-1356.
78. Powell-Jackson PR, Ede RJ, Williams R. Budd-Chiari syndrome presenting as fulminant hepatic failure. Gut 1986; 27: 1101-1105.
79. Rakela J, Perkins JD, Gross JB jr, Hayes DH, Plevak DJ, Krom RA, Ludwig J. Acute hepatic failure: the emerging role of orthotopic liver transplantation. Mayo Clinic Proceedings 1989; 64: 424-428.
80. Riely CA, Latham PS, Romero R, Duffy TP. Acute fatty liver of pregnancy: a reassessment based on observations in nine patients. Annals of Internal Medicine 1987; 106: 703-706.
81. Rolfes DB, Ishak KG. Acute fatty liver of pregnancy: a clinicopathologic study of 35 cases. Hepatology 1985; 5: 1149-1158.
82. Rolando N, Gimson AES, Wade J, Philpott-Howard J, Casewell M, Williams R. Prospective controlled trial of selective parenteral and enterai antimicrobial regimen in fulminant liver failure. Hepatology 1993; 17: 196-201.
83. Roland N, Harvey F, Brahan J, Philpott-Howard J, Gimson AES, Fagan E, Williams R. Prospective study of bacterial infection in acute liver failure: an analysis of fifty patients. Hepatology 1990; 11: 49-53.
84. Rozga J, Williams F, Ro MS, Neuzil DF, Giorgio TD, Backfisch G, Moscioni AD, Hakim R, Demetriou AA. Development of a bioartificial liver; properties and function of a hollow fibre module inoculated with liver cells. Hepatology 1993; 17: 258-265.
85. Rubin MH, Weston MJ, Bullock G, Roberts J, Langley PG, White YS, Williams R. Abnormal platelet function and ultrastructure in fulminant hepatic failure. Quarterly Journal of Medicine 1977; 183: 339-352.
86. Schafer DF, Shaw BW. Fulminant hepatic failure and orthotopic liver transplantation. Seminars in Liver Disease 1989; 9: 189-194.
87. Seda HMW, Hughes RD, Gove C, Williams R. Reduced brain Na-K ATPase activity by serum from patients with fulminant hepatic failure. Hepatology 1984; 4: 74-79.
88. 2) in the treatment of fulminant hepatic failure. Hepatology 1992; 16 (Suppl): S114 (abstract).
89. Sinclair SB, Greig PD, Blendis LM, Abecassis M, Roberts EA, Phillips MJ, Cameron R, Levy GA. Biochemical and clinical response of fulminant viral hepatitis to administration of prostaglandin E: a preliminary report. Journal of Clinical Investigation 1989; 84: 1063-1069.
90. Sussman NI, Gislason GT, Conlin CA, Kelly JH. The Hepatix extracorporeal liver assist device: initial clinical experience. Artificial Organs 1994; 18: 390-396.
91. Takahashi Y, Kumada H, Shimizu M, Tanikawa K, Kumashiro R, Omato M. A multicentre study on the prognosis of fulminant viral hepatitis: Early prediction for liver transplantation. Hepatology 1994; 9: 1065-1071.
92. Trewby PN, Warren R, Contini S, Crosbie WA, Wilkinson SP, Laws JW, Williams R. Incidence and pathophysiology of pulmonary edema in fulminant hepatic failure. Gastro-enterology 1978; 74: 859-865.
93. Trey C, Davidson CS. The management of fulminant hepatic failure. In: Popper H, Schaffner F, eds. Progress in Liver Diseases. Vol. III. New York: Grune & Stratton, 1970: 282-298.
94. Vickers C, Neuberger J, Buckels J, McMaster P, Elias E. Transplantation of the liver in adults and children with fulminant hepatic failure. Journal of Hepatology 1986; 7: 143-150.
95. Wendon JA, Gimson AE, Potter D. Oxygen uptake and delivery in fulminant hepatic failure. Care of the Critically III 1989; 5: 55-59.
96. Wendon JA, Harrison PM, Keays R, Gimson AES, Alexander GJM, Williams R. Effects of vasopressor agents and epoprostenol on systemic hemodynamics and oxygen transport in patients with fulminant hepatic failure. Hepatology 1992; 15: 1067-1071.
97. Wilkinson SP, Blendis LM, Williams R. Frequency and type of renal and electrolyte disorders in fulminant hepatic failure, British Medical Journal 1974; 1: 186-189.
98. Wilkinson SP, Weston MJ, Parsons V, Williams R. Dialysis in the treatment of renal failure in patients with liver disease. Clinical Nephrology 1977; 8: 287-292.
99. Williams R, Wendon J. Indications for orthotopic liver transplantation in fulminant hepatic failure. Hepatology 1994; 20: 5S-10S.
100. Wyke RJ, Rajkovic IA, Eddleston ALWF, Williams R. Defective opsonisation and complement deficiency in serum from patients with fulminant hepatic failure. Gut 1981; 21: 643-649.
101. Yoshiba M, Sekiyama K, Inoue K, Fujita R. Interferon and cyclosporin A in the treatment of fulminant viral hepatitis. Journal of Gastroenterology 1995; 30: 67-73.
102. Zafrani ES, Leclercq B, Vernant JP, Pinaudeau Y, Chomette G, Dhumeaux D. Massive blastic infiltration of the liver: a cause of fulminant hepatic failure. Hepatology 1983; 3: 428-432.
103. Zimmerman HJ, Ishak KG. Valproate-induced hepatic injury. Analysis of 23 fatal cases. Hepatology 1982; 2: 591-597.
104. Zimmerman H. Even enflurane (Editorial). Hepatology 1991; 13: 1251-1253.